Algorithm for therapy advancement in type 2 diabetes mellitus based on cardiorenal benefits. Adapted from Can J Diabetes. 2020 Oct;44(7):575-591 and 2022 guidelines from the American Diabetes Association and European Association for the Study of Diabetes.
